CytomX Announces Data to be Presented at the American Association for Cancer Research Annual Meeting 2016

CytomX Announces Data to be Presented at the American Association for Cancer Research Annual Meeting 2016

SOUTH SAN FRANCISCO Calif March 16 2016 GLOBE NEWSWIRE -- CytomX Therapeutics NasdaqCTMX a biopharmaceutical company developing investigational Probody therapeutics for the treatment of cancer today announced that preclinical results from i...